(Total Views: 609)
Posted On: 08/10/2019 4:48:42 PM
Post# of 145250
Yes great point! I wouldn’t be surprised if they have looked into the data but who knows. However, it is my understanding that since across the trials this has not been an endpoint (as far as I know) the data would carry zero weight and would not be worth the risk/not allowed in a PR
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)